Matthew P. Young, Director at PRA Health Sciences, Inc. (PRAH), sold 15,345 shares at $79.90 ($817K) on 2017-11-16, disclosed to the SEC on 2017-11-17.
Open-market sale of $817k PRAH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 5,115 | $0 | 0.0% |
| 2 | $79.90 | 5,115 | $409K | 50.0% |
| 3 | $79.90 | 5,115 | $409K | 50.0% |
| Total | $53.27 avg | 15,345 | $817K | 100% |
| Filing → |
| JAZZ | SELL | 2018-11-27 | $105K | — | Filing → |
| JAZZ | SELL | 2018-10-17 | $221K | — | Filing → |
| JAZZ | SELL | 2018-09-19 | $228K | — | Filing → |